In this exploratory study, we investigated the relationship between the gut microbiota and outcome in patients with metastatic hormone receptor‐positive breast cancer, treated in a randomized clinical trial with chemotherapy alone or chemotherapy in combination with immune checkpoint blockade.
Andreas Ullern +7 more
wiley +1 more source
Studies on genetic variability, heritability and genetic advance in okra [Abelmoschus esculentus (L.) Moench] [PDF]
Urmila B Bambhaniya +3 more
openalex +1 more source
Assessment of genetic advance and correlation coefficient for yield and yield attributed traits of RIL population in basmati rice (Oryza sativa L.) [PDF]
Madhvi Sharma +7 more
openalex
Modeling hepatic fibrosis in TP53 knockout iPSC‐derived human liver organoids
This study developed iPSC‐derived human liver organoids with TP53 gene knockout to model human liver fibrosis. These organoids showed elevated myofibroblast activation, early disease markers, and advanced fibrotic hallmarks. The use of profibrotic differentiation medium further amplified the fibrotic signature seen in the organoids.
Mustafa Karabicici +8 more
wiley +1 more source
Multi-omics and perturbation screens as discovery tools in immunometabolism. [PDF]
Chapman NM, Chi H.
europepmc +1 more source
Assessment of genetic variability, heritability and genetic advance for yield and physiological traits under late sown condition in bread wheat (Triticum aestivum L. em. Thell.) [PDF]
Santosh Santosh, JP Jaiswal
openalex
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert +13 more
wiley +1 more source
Studies on variability, heritability and genetic advance for yield and yield contributing characters in chilli (Capsicum annuum L.) [PDF]
S.C. Nahak +6 more
openalex
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser +14 more
wiley +1 more source

